Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Neuronetics Inc (STIM)

Healthcare Medical Devices
2.00 $
+0.5% vs. previous close
Closing price · As of: 31. Jul 2026

Who owns Neuronetics Inc (STIM)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 40.8% of the shares are freely tradable; institutional investors hold 60.0%.

Ownership Structure

Institutional ownership
60.0%
Insiders
32.4%
Float
40.8%
Short % of float
28.6%
Shares Outstanding
70Mio.

Largest Shareholders

Institutions

Institutions STIM
Name Stake (%) Shares Change (%) Date
Madryn Asset Management, LP 26.55 18,475,893 +0.0 03/31/2026
UBS Group AG 4.13 2,870,598 +10.1 03/31/2026
Balyasny Asset Management LLC 3.94 2,743,768 +7.5 03/31/2026
Vanguard Group Inc 3.71 2,582,382 -8.8 12/31/2025
BlackRock Inc 3.33 2,318,537 -1.5 03/31/2026
Vanguard Capital Management, LLC 2.94 2,047,975 +0.0 03/31/2026
Lane Generational LLC 2.55 1,774,624 +4.1 03/31/2026
FourWorld Capital Management LLC 2.14 1,489,322 +59.9 03/31/2026
Masters Capital Management LLC 1.44 1,000,000 +0.0 03/31/2026

Funds

Funds STIM
Name Stake (%) Shares Change (%) Date
Vanguard Total Stock Mkt Idx Inv 2.29 1,595,778 +0.0 04/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
23. Jul 2026 Naor Nir EVP, CFO & Treasurer Other 500,000 0.00
14. Jul 2026 Chernett Jorey 10% Owner Buy 35,000 1.78 62,300
20. Apr 2026 Jorey Chernett Major Shareholder Buy 100,000 1.58 158,000

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?